BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14603252)

  • 1. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
    Repovic P; Fears CY; Gladson CL; Benveniste EN
    Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
    Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
    Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
    Chen SH; Gillespie GY; Benveniste EN
    Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
    Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
    Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
    Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
    Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
    Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
    Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M signaling in human glioma cell lines.
    Krona A; Järnum S; Salford LG; Widegren B; Aman P
    Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of oncostatin M receptor beta in metastatic melanoma cells.
    Lacreusette A; Nguyen JM; Pandolfino MC; Khammari A; Dreno B; Jacques Y; Godard A; Blanchard F
    Oncogene; 2007 Feb; 26(6):881-92. PubMed ID: 16909117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of oncostatin M and its receptors in normal and cirrhotic human liver.
    Znoyko I; Sohara N; Spicer SS; Trojanowska M; Reuben A
    J Hepatol; 2005 Nov; 43(5):893-900. PubMed ID: 16169119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M: a pleiotropic cytokine in the central nervous system.
    Chen SH; Benveniste EN
    Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
    Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
    Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.
    Weiss TW; Simak R; Kaun C; Rega G; Pflüger H; Maurer G; Huber K; Wojta J
    Anticancer Res; 2011 Oct; 31(10):3273-8. PubMed ID: 21965736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor.
    Tamura S; Morikawa Y; Senba E
    Neuroscience; 2005; 133(3):797-806. PubMed ID: 15893881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.